Influence of body mass index and weight on etanercept efficacy in patients with psoriasis: A retrospective study.

J Int Med Res 2016 Sep;44(1 suppl):72-75

Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.

Aim: To investigate the role of body mass index (BMI) and weight in the long-term efficacy of etanercept in patients with psoriasis.

Methods: Medical records were retrospectively analysed. Extracted data included weight, BMI, comorbidities and psoriasis area severity index (PASI). Patients were stratified by weight (<80 kg or ≥80 kg) and BMI (healthy, BMI 22 - 24.99 kg/m; overweight, BMI 25 - 29.99 kg/m; obese, BMI ≥30 kg/m).

Results: The study included 66 patients. Body weight had no effect on etanercept efficacy. There was a significant reduction in etanercept efficacy in obese patients (n = 12) compared with healthy weight (n = 33) or overweight (n = 21) patients.

Conclusion: Obesity has a negative effect on the efficacy of etanercept in psoriasis.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300060515593254DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536536PMC
September 2016
4 Reads

Publication Analysis

Top Keywords

body mass
8
medical records
4
psoriasismethods medical
4
records retrospectively
4
patients psoriasismethods
4
retrospectively analysed
4
analysed extracted
4
etanercept patients
4
mass bmi
4
bmi weight
4
weight long-term
4
long-term efficacy
4
extracted data
4
data included
4
severity pasi
4
pasi patients
4
patients stratified
4
stratified weight
4
area severity
4
psoriasis area
4

Similar Publications